全文获取类型
收费全文 | 150篇 |
免费 | 11篇 |
国内免费 | 2篇 |
专业分类
163篇 |
出版年
2022年 | 2篇 |
2019年 | 4篇 |
2017年 | 3篇 |
2016年 | 4篇 |
2015年 | 6篇 |
2014年 | 2篇 |
2013年 | 7篇 |
2012年 | 9篇 |
2011年 | 3篇 |
2010年 | 2篇 |
2009年 | 3篇 |
2008年 | 6篇 |
2007年 | 3篇 |
2006年 | 3篇 |
2004年 | 7篇 |
2002年 | 5篇 |
2001年 | 5篇 |
2000年 | 2篇 |
1999年 | 4篇 |
1998年 | 6篇 |
1997年 | 2篇 |
1996年 | 2篇 |
1993年 | 4篇 |
1992年 | 2篇 |
1987年 | 3篇 |
1986年 | 2篇 |
1984年 | 3篇 |
1977年 | 2篇 |
1976年 | 2篇 |
1963年 | 4篇 |
1961年 | 3篇 |
1959年 | 3篇 |
1958年 | 3篇 |
1956年 | 3篇 |
1955年 | 2篇 |
1954年 | 1篇 |
1950年 | 1篇 |
1949年 | 1篇 |
1948年 | 1篇 |
1940年 | 1篇 |
1939年 | 2篇 |
1938年 | 1篇 |
1937年 | 1篇 |
1934年 | 1篇 |
1929年 | 1篇 |
1923年 | 2篇 |
1918年 | 4篇 |
1910年 | 2篇 |
1902年 | 2篇 |
1888年 | 1篇 |
排序方式: 共有163条查询结果,搜索用时 0 毫秒
11.
For anti-tumor therapy different strategies have been employed, e.g., radiotherapy, chemotherapy, or immunotherapy. Notably, these approaches do not only address the tumor cells themselves, but also the tumor stroma cells, e.g., endothelial cells, fibroblasts, and macrophages. This is of advantage, since these cells actively contribute to the proliferative and invasive behavior of the tumor cells via secretion of growth factors, angiogenic factors, cytokines, and proteolytic enzymes. In addition, tumor stroma cells take part in immune evasion mechanisms of cancer. Thus, approaches targeting the tumor stroma attract increasing attention as anti-cancer therapy. Several molecules including growth factors (e.g., VEGF, CTGF), growth factor receptors (CD105, VEGFRs), adhesion molecules (alphavbeta3 integrin), and enzymes (CAIX, FAPalpha, MMPs, PSMA, uPA) are induced or upregulated in the tumor microenvironment which are otherwise characterized by a restricted expression pattern in differentiated tissues. Consequently, these molecules can be targeted by inhibitors as well as by active and passive immunotherapy to treat cancer. Here we discuss the results of these approaches tested in preclinical models and clinical trials. 相似文献
12.
Generation of macrophages from early T progenitors in vitro 总被引:3,自引:0,他引:3
Lee CK Kim JK Kim Y Lee MK Kim K Kang JK Hofmeister R Durum SK Han SS 《Journal of immunology (Baltimore, Md. : 1950)》2001,166(10):5964-5969
Early T progenitors in the thymus have been reported to have the capacity to develop into B cells, thymic dendritic cells, and NK cells. Here we describe conditions that induce early T progenitors to develop into macrophages. Initially, we observed that early T progenitors could be induced to develop into macrophages by cytokines produced from a thymic stromal cell line, TFGD, and later we found that the cytokine mixture of M-CSF plus IL-6 plus IL-7 also induced macrophage differentiation from pro-T cells. M-CSF by itself was unable to induce macrophage differentiation from early T progenitors. To correlate this observation with the developmental potential of early T progenitors, mouse embryonic thymocytes were sorted into four populations, pro-T1 to pro-T4, based on the expression of CD44 and CD25, and then cultured with TFGD culture supernatant. We found that pro-T1 and pro-T2 cells, but not pro-T3 and pro-T4 cells, generate macrophages. Limiting dilution analysis of the differentiation capability of sorted pro-T2 cells also confirmed that pro-T2 cells could generate macrophages. These results suggest that T cells and thymic macrophages could originate from a common intrathymic precursor. 相似文献
13.
Generation of histocompatible tissues using nuclear transplantation 总被引:27,自引:0,他引:27
14.
ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice 总被引:3,自引:0,他引:3 下载免费PDF全文
Smith JL Schaffner AE Hofmeister JK Hartman M Wei G Forsthoefel D Hume DA Ostrowski MC 《Molecular and cellular biology》2000,20(21):8026-8034
15.
16.
17.
18.
19.
Hofmeister V Vetter C Schrama D Bröcker EB Becker JC 《Cancer immunology, immunotherapy : CII》2006,55(5):481-494
Immunotherapy has been widely investigated for its potential use in cancer therapy and it becomes more and more apparent that the selection of target antigens is essential for its efficacy. Indeed, limited clinical efficacy is partly due to immune evasion mechanisms of neoplastic cells, e.g. downregulation of expression or presentation of the respective antigens. Consequently, antigens contributing to tumor cell survival seem to be more suitable therapeutic targets. However, even such antigens may be subject to immune evasion due to impaired processing and cell surface expression. Since development and progression of tumors is not only dependent on cancer cells themselves but also on the active contribution of the stromal cells, e.g. by secreting growth supporting factors, enzymes degrading the extracellular matrix or angiogenic factors, the tumor stroma may also serve as a target for immune intervention. To this end several antigens have been identified which are induced or upregulated on the tumor stroma. Tumor stroma-associated antigens are characterized by an otherwise restricted expression pattern, particularly with respect to differentiated tissues, and they have been successfully targeted by passive and active immunotherapy in preclinical models. Moreover, some of these strategies have already been translated into clinical trials. 相似文献
20.
Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response 总被引:7,自引:0,他引:7
Scriba TJ Kalsdorf B Abrahams DA Isaacs F Hofmeister J Black G Hassan HY Wilkinson RJ Walzl G Gelderbloem SJ Mahomed H Hussey GD Hanekom WA 《Journal of immunology (Baltimore, Md. : 1950)》2008,180(3):1962-1970
We investigated whether the proinflammatory T cell cytokines IL-17 and IL-22 are induced by human mycobacterial infection. Remarkably, >20% of specific cytokine-producing CD4(+) T cells in peripheral blood of healthy, mycobacteria-exposed adults expressed IL-17 or IL-22. Specific IL-17- and IL-22-producing CD4(+) T cells were distinct from each other and from Th1 cytokine-producing cells. These cells had phenotypic characteristics of long-lived central memory cells. In patients with tuberculosis disease, peripheral blood frequencies of these cells were reduced, whereas bronchoalveolar lavage fluid contained higher levels of IL-22 protein compared with healthy controls. IL-17 was not detected in this fluid, which may be due to suppression by Th1 cytokines, as PBMC IL-17 production was inhibited by IFN-gamma in vitro. However, Th1 cytokines had no effect on IL-22 production in vitro. Our results imply that the magnitude and complexity of the anti-mycobacterial immune response have historically been underestimated. IL-17- and IL-22-producing CD4(+) T cells may play important roles in the human immune response to mycobacteria. 相似文献